Investegate |Oxford BioDynamics Announcements | Oxford BioDynamics: Initial assessment of EpiSwitch assay in ALS trial
Investegate announcements from Oxford BioDynamics, Initial assessment of EpiSwitch assay in ALS trial
Source: investegate.co.uk
Stay updated with breaking news from Agnes Stephens. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Oxford BioDynamics, Initial assessment of EpiSwitch assay in ALS trial
Investegate announcements from Evgen Pharma PLC, Grant of Options - Director/PDMR Shareholding
Touchlight and Odimma have entered into an agreement to develop and supply clinical material for Odimma's neoantigen program Touchlight, a biotechnology company pioneering enzymatic DNA production
Investegate announcements from Evgen Pharma PLC, Notice of Half Year Results
Investegate announcements from ,